Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PMGC HoldingsELAB +6.33%8 Days Payable is 95.56 as of Jun. 2026, which is 73% below its 10-year median of 354.03. GuruFocus rates ELAB with a GF Score™ of 8/100. The stock has 3 warning signs investors should review. Among 706 Biotechnology companies, PMGC Holdings ranks better than 55.52% on this metric.
The historical data trend for PMGC Holdings's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, PMGC Holdings's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PMGC Holdings Days Payable vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, PMGC Holdings's Days Payable distribution charts can be found below:
* The bar in red indicates where PMGC Holdings's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
PMGC Holdings's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PMGC Holdings (ELAB) has a Days Payable of 95.56 as of Jun. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on PMGC Holdings and its competitors. This is 73% below median its historical median of 354.03. Over the past decade, PMGC Holdings' Days Payable has ranged from 141.77 to 531.28. According to the industry distribution chart, PMGC Holdings ranks #314 out of 706 companies in the Biotechnology industry, placing it in the top 44.5%.
Is PMGC Holdings' Days Payable too high?
PMGC Holdings' current Days Payable of 95.56 is 73% below median its 10-year median of 354.03. Over the past 10 years, this metric has ranged from a low of 141.77 to a high of 531.28. The Biotechnology industry median Days Payable is 110.85. PMGC Holdings' value of 95.56 is 13.8% below this industry median. Based on the distribution chart, PMGC Holdings ranks #314 out of 706 companies in the Biotechnology industry, which is above the industry midpoint. Overall, PMGC Holdings has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does PMGC Holdings' Days Payable compare to REVB and ENSC?
According to the Biotechnology industry distribution chart, PMGC Holdings ranks #314 out of 706 companies for Days Payable. This puts PMGC Holdings in the upper half of its industry. The industry median Days Payable is 110.85. PMGC Holdings' value of 95.56 is 13.8% below this benchmark. Historically, PMGC Holdings' own Days Payable has ranged from 141.77 to 531.28 over the past decade. While the company's 10-year median is 354.03 vs. the industry median of 110.85, PMGC Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 110.85, based on 706 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PMGC Holdings's current Days Payable of 95.56 is 13.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on PMGC Holdings and its competitors. For the Biotechnology industry, the median Days Payable is 110.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PMGC Holdings's current Days Payable is 95.56, which is 73% below median its own 10-year median of 354.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PMGC Holdings stock overvalued right now?
PMGC Holdings (ELAB) has a current Days Payable of 95.56. The current Days Payable is 95.56, which is 73% below median its 10-year median of 354.03 and 13.8% below the Biotechnology industry median of 110.85. PMGC Holdings' overall GF Score™ is 8/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For PMGC Holdings (ELAB), the current Days Payable is 95.56 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PMGC Holdings Inc IS advancing in Medical Aesthetics and Biopharmaceutical Innovation. It specializes in Skin Aesthetics, Obesity, and Metabolic Health business.
8GF Score
Get the complete analysis for ELAB
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ELAB has been successfully added to your 
